BioSpace News Archive

ORHub, Inc. today announces the planned implementation of its Surgical SpotlightTM data analytics platform across three health systems in California and Florida.

Company is seeking to contract with a hospital group, purchasing organization or other pharmaceutical manufacturer to make one or more sterile injectable drugs that will provide significant cost savings.

Hires Commercial and CMC Heads from Celgene

Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that its Chairman and Chief Executive Officer, Rodney Varner, will present at the 11th annual LD Micro Main Event at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.

Brand-name drug companies’ research and development spending as a percentage of sales in Canada is less than half of the 10 percent the industry committed to when their periods of market exclusivity were first increased in 1987, according to the most recent annual report from the federal government’s Patented Medicine Prices Review Board (PMPRB).

Partnership Garners Genetic Testing To Provide Scope Of Overall Health

Evogen/Cognizance Biomarkers’ Blood-Based Biomarker Test Has Potential to Transform Costly, Time-Consuming and Imprecise Diagnosis of Epilepsy

PiSA BioPharm, an emerging medical device and pharmaceutical company, announced today at the American Society of Health-System Pharmacists Midyear 2018 Clinical Meeting and Exhibition the launch of its new family of empty non-PVC TPN (Total Parenteral Nutrition) bags with DEHP-free ports.

44% of transfusion dependent myelofibrosis patients (multi-study aggregate N=152) were transfusion free for at least 12 weeks; 49% were transfusion free for at least 8 weeks

Alteogen Inc. and Lynkogen Inc. today announced that they have expanded the scope of their exclusive option agreement. In addition to the originally announced GLP-1 mimetic fusion proteins, Lynkogen will also acquire exclusive rights to FGF21 fusions, including dual function FGF21/GLP-1 mimetic fusion protein.